sodium ferric gluconate complex Report issue

Small molecule Approved FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Sodium ferric gluconate complex, sold under the brand name Ferrlecit, is an intravenously administered iron medication for the treatment of iron deficiency anemia in adults and in children aged six years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. The macromolecule has an apparent molecular weight of 289,000 – 440,000 Dalton.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$7.0350
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

apo-ferrous gluconate | dextriferron | eisen-sandoz | feg iron | fergon | ferric gluconate | ferric gluconate anhydrous | ferric gluconate, sodium salt | ferric gluconate trihydrate | ferric sodium gluconate complex | ferrlecit | ferrlecit 100 | ferroglucon | ferrogluconaat fna | ferroglyconicum | ferrous gluconate | ferrum verla | glucoferron | iron gluconate | loesferron | losferron | rulofer g | sideromal | simron | sodium ferric gluconate | sodium ferric gluconate complex | sodium ferric gluconate complex in sucrose | sodium ferrigluconate | sodium iron(iii)gluconate | vitaferro brause

Organizations (26)

Research & Development (23)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (18)

Approved Indications (1)


 

Anemia

Experimental Indications - Clinical Trial Phases 1-4 (18)


 

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Aortic Valve Stenosis (Phase 4)

Bariatric Surgery (Phase 4)

Gastric Bypass (Phase 4)

Heart Failure (Phase 4)

Inflammatory Bowel Diseases (Phase 3)

Iron Deficiencies (Phase 4)

Iron Overload (Phase 2)

Kidney Failure, Chronic (Phase 4)

Leukemia (Phase 3)

Lymphoma (Phase 3)

Lymphoproliferative Disorders (Phase 3)

Multiple Myeloma (Phase 3)

Neoplasms (Phase 3)

Precancerous Conditions (Phase 3)

Renal Dialysis (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 25
  • # of Trial Organizations: 23

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue